Donald Trump faces declining approval ratings and new testosterone-focused policies

Donald Trump is facing declining approval ratings as the midterm elections approach. Recent polling indicates his numbers are dropping to levels comparable to the lowest approval ratings seen during the Biden administration. Voters have expressed dissatisfaction regarding the cost of living, including high diesel fuel prices and mortgage rates, as well as the administration's handling of the Iran war.

In an effort to appeal to male voters, the administration has introduced policies related to testosterone. Health Secretary Robert F. Kennedy Jr. announced that the FDA is removing limitations on testosterone replacement therapy (TRT), potentially increasing prescriptions. Additionally, Defense Secretary Pete Hegseth has implemented compulsory testosterone screening for military service members over the age of 30, offering state-sponsored replacement therapy for those with low levels.

Political figures are also utilizing these themes in campaigns. For example, Ken Paxton has used testosterone levels as a rhetorical tool in his Texas Senate campaign to criticize opponents.